skip to Main Content
(212) 203-2813 115 E. 57th St. STE 1210 • New York, NY 3675 E Tremont Ave • Bronx, NY
SystemReferencePREPARATION   PLATELET RICH PLASMA   PLATELET-DERIVED GROWTH FACTORS (PDGF)   White Blood Cells (units vary)Additional Notes
CentrifugeBlood Vol (mL)Force (g) Cent Time (min)PRP Vol (mL)PRP Conc. (Platelet/μL)PRP Conc. SD (+/-)Factor Increase (System PRP/Whole Blood PRP)PDGF-AB (ng/mL)PDGF-BB (ng/mL)TGF-B1 (pg/mL)VEGF (ng/mL)
Castillo, 20112.788 x10 56.4 x 10 3 /μL
Mandle, 20141.548 x 10 5(+/-35000)
Anitua ProtocolMarx, 20044.33 x 10 53552
Landesberg ProtocolMazzucco, 2008601801010.6 (+/-2.4)unknown33 (+/-7)50
Kevy, 20061.643 x 10 122.0 x 10 9 /μL
Kevy, 20061.567 x 10 122.4 x 10 9 /μL
Kushida, 20141.78 x 10 5
Friadent-Schutze ProtocolWeibrich, 20034825152.1 x 10 6251.6196.8
Arteriocyte MagellanPRP™Castillo, 20112612001767.802 x10 5(+/-24700)x2.8 34.4(+/-10.7)33.0 (+/-8.2)200 (+/-100)1.2 (+/-0.8)1.10 x10 4 /μL (+/-8200)
Kushida, 2014260610 & 20004, 631.521 x10 6x9.0574.81.7190 x10 34714.4/μL
Arthrex
Biomet GPS®IIKaux, 2011606.2
Biomet GPS®IIICastillo, 20115511001565.662 x10 5(+/-292600)x2.07 18.7 (+/-12.8)23.1 (+/-10.1)100 (+/-8)2.4 (+/-1.1)3.44 x10 4 /μL (+/-13600)
Kaux, 2011523200 (rpm)156.6unknownx7.3 to 8.32.75410 x 10 5 / μL
Curasan®Marx, 20047.6(+/-1.5)3.44x10 5(+/-192000)x1.7239 (+/-11.4)3.9x10 4 (+/-11400)
Mazzucco, 200815180107.6(+/-1.6)unknown35 (+/-17)
Cytomedix Angel® PRP
Cytonics® APIC
Emcyte Pure PRP® IIMandle, 2014752.5 & 57.41.0676 x 10 6(+/- 253000)x6.9+/-0.7
Fibrinet®Lucarelli, 20102181100, 45006, 25unknownx210291.0000 x 10 40.225
Mazzucco, 20088180104.4(+/-0.2)unknown105 (+/-30)Activator: Ca++, high speed centrifugation
Genesis CSEverts, 2006532.239x 10 5 x1.021.45995 x 10 5 pg (+/-61259) thrombin activated8.798 x 10 3 pg (+/-2301) thrombin activated 0.144 (+/- 0.049)thrombin activated, measured in pg instead of concentration for PDGF-AB and TGF-B1
Kevy, 200660 2400 (rpm)121.642 x10 6 , 1.567 x10 6x9.12, x8.712.0 x10 4 /μL, 2.3 10 4 /μL (+/-7400, +/-8900)Concentration Platelet Product analyzed at 0hr, 4hr
GLO PRPKushida, 201428.51800, 18003, 60.68.91 x10 2x0.005367.31.3 x10 338 (exact value not given)
Harvest® Smart PRePMarx, 20047.4 (+/- 0.5)1.086 x 10 6(+/-227000)x5.43133 (+/-29.2)1.7x10 5 (+/-42300)
Mazzucco, 2008501801010.0 (+/- 0)unknown133 (+/-29)Activator: Ca++, thrombin
Weibrich, 2003females: 52ml; males: 48ml1271.227890 x 10 6 x4.432.08 x10 2 (+/-85.2)7.72x 10 4 (+/-54800)19.261 x 10 3 (+/-8082) platelets/μL
MTF Cascade® PRP Castillo, 201118110067.54.438 x10 5(+/-24700)x1.629.7 (+/-3.6)14.8 (+/-2.5)100 (+/-8)0.3 (+/-0.3)1.1 x10 3 /μL (+/-200)
Arthrex, 2014291100, 1450 6, 154.1 (+/-0.5)1.36 x 10 5 (+/-61000)x0.75.307(+/-3.170)

Corey Hunter, M.D.

Founder at Ainsworth Institute
Dr. Corey Hunter is a nationally recognized interventional pain physician and the founder of Ainsworth Insitute. His publications have appeared in textbooks on treating pain and he is a regular contributor in leading pain management journals.